What Happens When Payers and Providers Both Have AI: The New Claims Adjudication Landscape

The U.S. healthcare system spends $262 billion a year on claims denial friction. Payers deploy AI to scrutinize and deny. Providers — most of them — still fight back with spreadsheets, phone holds, and fax machines. The result is a lopsided contest that costs the average health system $4.5 million annually in preventable revenue loss.

But this asymmetry has an expiration date.

Provider-side AI is maturing rapidly. Platforms that predict denials before submission, scrub claims against payer-specific logic, and generate targeted appeals are moving from early adoption to mainstream deployment. A 2025 HFMA survey found that 67% of health system CFOs had already implemented or were actively piloting AI in revenue cycle operations. By 2027, the majority of mid-size and large provider organizations will have AI capabilities that rival what payers have spent a decade building.

Which raises a question that nobody in healthcare has fully answered: what happens when both sides have mature AI?

This isn't a theoretical exercise. The answer to this question determines how provider organizations should invest, what technology architecture they should build, and what claims adjudication will look like in three, five, and ten years. The decisions revenue cycle leaders make today will determine whether their organizations thrive in the AI-mediated claims future — or get caught in a technology gap they can't close.

The Current State: Payer AI Has a Head Start

To understand where claims adjudication is headed, you have to understand where it is now.

Major health insurers have been deploying machine learning in claims processing for over a decade. UnitedHealth Group, Cigna, Anthem, Aetna, and Humana have each invested hundreds of millions of dollars in AI systems that automate the entire claims lifecycle. These systems apply 50,000 or more clinical editing rules to every claim, auto-adjudicate 70-85% of submissions without human review, score each claim on a denial probability scale, and continuously learn from outcomes to improve their accuracy.

The result: payers can deny a claim in milliseconds at near-zero marginal cost. The AI identifies the statistical anomaly, selects the denial reason, generates the denial letter, and moves on to the next claim. No human involvement. No cognitive burden. No backlog.

On the provider side, the picture is different. According to multiple industry surveys, the majority of provider organizations still manage claims using a combination of first-generation clearinghouse edits, manual review processes, template-based appeal letters, and reactive denial management workflows. The cost of appealing a single denial is $25 to $50 in staff time. The average appeal takes 30 to 90 days. And an estimated 35-50% of denied claims are never appealed at all — the dollar value is too low or the staff is too stretched.

This asymmetry is the defining feature of the current claims adjudication landscape. It explains why initial denial rates have climbed from 9% in 2016 to over 15% in 2025. It explains why providers report spending more on denial management every year despite no change in clinical practice. And it explains why the payer-provider relationship feels, to many revenue cycle leaders, like a fight they can't win.

The Near-Term: Provider AI Matches Payer AI Capability (2025-2027)

The asymmetry is closing. Fast.

Provider-side AI platforms have reached a level of maturity where they can match — and in some cases exceed — payer AI capabilities in the domains that matter most: denial prediction, claims scrubbing, eligibility verification, coding optimization, and appeal generation.

What provider AI can do today

Predict denials before submission with 85-95% accuracy. Machine learning models trained on hundreds of millions of historical claims can identify which specific claims will be denied, by which payer, for which reason, before the claim leaves the building. This isn't speculative — it's deployed at scale across hundreds of healthcare organizations.

Apply payer-specific scrubbing logic. Provider AI systems now maintain real-time models of each payer's denial behavior — not just their published rules, but their actual adjudication patterns. When a payer starts denying a procedure-diagnosis combination that it previously accepted, the provider AI detects the shift within days and adjusts its scrubbing logic automatically.

Generate targeted, evidence-based appeals. When denials occur, AI can categorize the denial by root cause, identify the specific documentation each payer requires to overturn that denial type, and generate an appeal letter with the clinical evidence attached. Organizations using AI-driven appeals report overturn rates of 60-70%, compared to 40-50% for manual appeals.

Optimize coding in real time. Natural language processing reads clinical documentation and suggests the most specific, accurate codes — not by matching keywords, but by understanding clinical context. This eliminates the undercoding that leaves revenue on the table and the specificity gaps that trigger payer denials.

The timeline for parity

The technology exists now. Adoption is the variable. Based on current implementation rates, the majority of provider organizations above $50 million in annual revenue will have deployed AI-native revenue cycle technology by mid-2027. Smaller organizations will follow within 12-18 months, driven by vendor accessibility, competitive pressure, and the increasingly obvious ROI math — platforms in this space are reporting payback periods under 90 days.

When that adoption wave completes, the current asymmetry disappears. Payers will no longer face providers who bring spreadsheets to a machine learning fight. They will face providers whose AI systems are purpose-built to counter payer AI systems. Claim by claim. Payer by payer. In real time.

The Equilibrium Question: What Happens When Both Sides Can Predict Each Other?

This is where claims adjudication enters uncharted territory.

When payer AI can predict which claims to deny, and provider AI can predict which claims will be denied and pre-correct them, the system reaches a strategic equilibrium — a point where each side's AI has fully modeled the other side's behavior. The payer knows the provider will optimize its claims. The provider knows the payer knows. The models converge.

Game theory offers a framework for understanding what happens next. When two rational actors with complete information about each other's strategies interact repeatedly, the outcome depends on the incentive structure. In the claims adjudication context, three scenarios are plausible — and the healthcare industry will likely experience elements of all three.

Scenario 1: Adversarial Escalation

In this scenario, payer and provider AI systems enter an escalating cycle of move and countermove — each side deploying increasingly sophisticated models to outmaneuver the other.

How it plays out

Provider AI learns to structure claims that pass payer scrutiny at the highest reimbursement level supported by the clinical documentation. Payer AI responds by deploying deeper documentation analysis — reading the clinical notes themselves, not just the claim fields — to identify cases where documentation quality has been optimized for billing rather than reflecting clinical reality. Provider AI counters by improving documentation in ways that satisfy both clinical and billing requirements simultaneously. Payer AI escalates to behavioral analysis, flagging providers whose documentation improvement patterns suggest AI optimization.

This is the cybersecurity parallel: an offensive-defensive arms race where each improvement by one side triggers a response from the other. In cybersecurity, this dynamic has produced increasingly sophisticated attack and defense technologies over decades, with no sign of equilibrium.

The costs

The adversarial scenario is expensive for everyone. Both sides invest more in AI infrastructure, more in model development, more in data acquisition. The administrative cost of claims processing — already $265.6 billion annually, per JAMA — increases rather than decreases. Neither side gains a lasting advantage. The complexity of the system grows, making it harder for smaller organizations on either side to compete.

Who it hurts most

Small and mid-size providers without the resources to keep pace with AI escalation. Small and mid-size payers who can't match the AI investment of national carriers. And patients, who bear the cost of an administrative system that consumes more resources without improving care.

How likely is it?

Partially likely. Some degree of adversarial escalation is already happening and will continue. But pure adversarial escalation — without any moderating force — is unlikely to persist indefinitely, because it creates costs that neither side can sustain and regulatory attention that neither side wants.

Scenario 2: Collaborative Optimization

In this scenario, payer and provider AI systems evolve toward direct communication — negotiating claims in real time, resolving disputes algorithmically, and reducing the friction that generates administrative waste.

How it plays out

Instead of the current sequential process — provider submits claim, payer adjudicates, payer denies, provider appeals, repeat — AI systems on both sides begin exchanging structured data before formal claim submission. The provider's AI sends a pre-adjudication query: "This is the clinical scenario, this is the proposed billing, does this meet your medical necessity criteria?" The payer's AI responds in real time: "Yes, at this reimbursement level" or "No, but it would meet criteria with this additional documentation." The claim is resolved before it becomes a denial.

This is not fantasy. It's the logical extension of electronic prior authorization, which CMS is already mandating for Medicare and Medicaid programs through its 2026 interoperability rules. The technology infrastructure for real-time payer-provider data exchange is being built now. The step from electronic prior authorization to AI-mediated pre-adjudication is architectural, not conceptual.

The economics

The collaborative scenario is dramatically cheaper for both sides. The cost of a real-time AI-to-AI pre-adjudication query is measured in fractions of a cent — compute time, API calls, data processing. The cost of a traditional denial-and-appeal cycle is $25-$118 per claim, depending on the study. If AI-to-AI negotiation eliminates even 50% of the denial-and-appeal cycle, the annual savings to the U.S. healthcare system would exceed $50 billion.

Provider organizations would benefit disproportionately, because they currently bear the higher cost in the denial-appeal cycle. Payers would benefit from reduced claims processing overhead and reduced regulatory scrutiny around denial practices.

The barriers

The collaborative scenario requires payers to participate — and payers' current financial incentive is to maintain complexity, not reduce it. Denials that are never appealed represent pure profit. Delays in payment generate time-value-of-money returns. Any system that makes claims resolution faster and more transparent reduces these financial benefits.

This is why collaboration probably won't emerge purely from market forces. It will require a push — either from regulation or from the competitive pressure of providers who refuse to contract with payers that won't participate in AI-mediated resolution.

How likely is it?

Moderately likely, but not in the near term. Elements of collaborative optimization will emerge over 2027-2030, initially in Medicare and Medicaid (where CMS can mandate participation) and later in commercial markets. Full AI-to-AI claims negotiation is a 2030-plus development.

Scenario 3: Regulatory Intervention

In this scenario, federal and state regulators step in to define the rules of engagement for AI in claims adjudication — limiting what both sides can do and mandating transparency in how AI decisions are made.

How it plays out

Regulatory intervention is already underway. CMS's prior authorization reforms, effective 2026, require payers in Medicare and Medicaid programs to support electronic authorization, provide faster decisions, and offer greater transparency into denial reasoning. Proposed CMS rules would require health plans to disclose when AI is used in coverage determinations. Multiple state legislatures have introduced bills requiring human review of AI-driven denial decisions and mandating disclosure of AI use in claims adjudication.

The trajectory is clear: regulators are moving toward a framework where AI in claims adjudication must be transparent, explainable, and subject to meaningful oversight. The specific regulations will evolve, but the direction is set.

What regulation might look like by 2028-2030

AI transparency mandates. Payers must disclose to providers and patients when AI contributed to a coverage determination. Denial letters must identify whether AI was involved in the decision and provide the specific factors that drove the denial — not just generic reason codes.

Algorithmic fairness requirements. Payer AI must demonstrate that its denial patterns do not disproportionately affect specific patient populations, geographies, or provider types. Disparate impact analysis — already a concept in employment law and lending regulation — extends to claims adjudication.

Appeal parity rules. If a payer uses AI to deny a claim in milliseconds, the provider must be permitted to appeal using AI-generated evidence at equivalent speed. The current system — where payer AI denies instantly and provider humans must appeal manually within strict filing deadlines — may be deemed structurally unfair.

Interoperability requirements. Payers must support standardized APIs that allow provider AI systems to query coverage rules, verify medical necessity criteria, and submit pre-adjudication inquiries electronically. This eliminates the information asymmetry where payers know their own rules but providers must reverse-engineer them from denial patterns.

Who benefits

Regulation benefits providers and patients by constraining the most aggressive payer AI behaviors. It benefits smaller organizations that can't match the AI investment of larger competitors. It potentially slows innovation by limiting what AI systems are permitted to do.

Who it challenges

Organizations — on both sides — that have invested heavily in proprietary AI advantages. If regulation mandates transparency in adjudication logic, the competitive advantage of having a better black-box algorithm diminishes. The advantage shifts from "best algorithm" to "best data" and "best implementation."

How likely is it?

Highly likely. Some form of regulatory intervention in AI-driven claims adjudication is virtually certain by 2028. The political dynamics — bipartisan concern about health insurance denials, patient advocacy group pressure, state attorney general investigations into algorithmic denial practices — make inaction politically untenable. The only question is scope and specificity.

The Data Advantage: Why the Provider with Better AI Still Wins

Regardless of which scenario dominates — adversarial escalation, collaborative optimization, or regulatory intervention — one principle holds across all three: the provider with better AI and better data achieves better financial outcomes.

In an adversarial scenario

The provider with superior denial prediction catches more denials before submission. The provider with payer-specific behavioral models adapts faster to payer rule changes. The provider with NLP-powered documentation optimization generates notes that withstand the most sophisticated payer scrutiny — not because the notes are gamed, but because they're clinically comprehensive.

The financial gap between a provider at 6% denial rate and one at 12% denial rate is approximately $3 million per $50 million in revenue. In an adversarial escalation scenario, that gap persists or widens because the advantage goes to the organization with the more adaptive AI.

In a collaborative scenario

AI-to-AI claims negotiation rewards the provider whose AI system can most effectively represent the clinical case. When a payer's AI queries the clinical basis for a claim, the provider whose AI can instantly assemble the relevant documentation, map it to the payer's specific medical necessity criteria, and present it in the required format will achieve higher first-pass resolution rates than the provider whose AI capability is less developed.

Even in a world where claims are settled by algorithm, the quality of the algorithm matters.

In a regulatory scenario

If regulation mandates transparency in payer adjudication logic, every provider gains access to the same information about payer rules. The advantage shifts from information asymmetry to execution speed — which provider can most quickly adapt its claims processes to the transparent payer rules. This is an AI capability question: the provider with the more responsive, more adaptive AI system acts on the transparent information faster.

The compounding data advantage

There is a deeper advantage that grows over time. AI systems improve with data. A provider organization that has been running AI-native revenue cycle operations for three years has a model trained on hundreds of thousands of its own claims, denials, appeals, and outcomes — specific to its payer mix, its clinical specialties, its documentation patterns. That institutional knowledge, embedded in the AI, is a competitive asset that a new AI deployment cannot replicate overnight.

This is why the timing of AI adoption matters even in a world where the specific competitive dynamics are uncertain. The provider that starts building its data advantage today will have a structural edge that compounds with every claim processed.

What This Means for Revenue Cycle Strategy Today

The future of claims adjudication is uncertain in its specifics but directional in its implications. Whether the endgame is adversarial, collaborative, regulatory, or — most likely — a combination of all three, the strategic imperatives for provider organizations are the same.

Imperative 1: Deploy AI-native revenue cycle technology now

The current ROI on provider-side AI is driven by the existing asymmetry — providers catching up to payer AI capabilities. This ROI is real and immediate. But the strategic value goes beyond today's returns. Every month of AI operation builds the data asset and institutional intelligence that will determine competitive position in whatever future scenario emerges.

Organizations that deploy AI in 2026 will have two to three years of compounding model improvement by the time the claims adjudication landscape reaches its next inflection point. Organizations that wait until 2028 will be starting from scratch while their competitors are operating on mature, organization-specific models.

Imperative 2: Choose AI architecture over AI features

In a world where claims adjudication becomes AI-mediated on both sides, the provider's technology architecture determines its ceiling. A platform with AI bolted onto legacy rules-based infrastructure can't adapt at the speed that adversarial escalation demands. It can't participate in AI-to-AI collaborative negotiation. It can't leverage regulatory transparency requirements at the execution speed that creates advantage.

AI-native architecture — where machine learning is the foundational layer, where every function feeds data back to every other function, where the system improves continuously without manual rule updates — is the architecture that survives and thrives across all three scenarios. Point solutions and AI-washed legacy platforms will reach capability ceilings that their architecture cannot transcend.

Imperative 3: Build payer behavior intelligence as a strategic asset

Regardless of the scenario, understanding payer behavior at a granular level — which payers deny which claims for which reasons, how those patterns change over time, how each payer's AI responds to different documentation and coding approaches — is the data asset that powers every AI capability.

This intelligence informs denial prevention (pre-adapting claims to each payer's patterns), appeal strategy (targeting appeals based on overturn probability by payer and denial type), contract negotiation (presenting data-driven evidence of unreasonable denial practices), and competitive positioning (achieving lower denial rates than peers who lack the same intelligence).

Building this intelligence requires processing volume — the more claims an AI system processes with a given payer, the more precisely it models that payer's behavior. Organizations that start building this intelligence now create a compounding advantage that later entrants cannot quickly replicate.

Imperative 4: Prepare for regulatory change

The regulatory landscape for AI in healthcare is evolving rapidly. Provider organizations should monitor CMS rulemaking on AI transparency, track state-level legislation on algorithmic denial practices, ensure that their own AI systems operate with full audit trails and explainable outputs, and advocate — through industry organizations like HFMA, MGMA, and the AMA — for regulatory frameworks that mandate payer transparency and AI accountability.

Organizations with AI systems that already operate transparently and with documented audit trails will be compliance-ready when new regulations take effect. Organizations that must retrofit transparency into opaque systems will face disruption.

Preparing Your Organization for the AI-Mediated Claims Future

Strategic imperatives are only valuable if they translate into operational action. Here is a practical preparation framework organized by timeframe.

Now through Q4 2026: Foundation

Measure your baseline. Document your current denial rate by payer and denial category, your appeal rate and overturn rate, your days in AR, your cost-to-collect, and your net collection rate. These metrics establish the benchmark against which AI performance will be measured — and they quantify the cost of inaction.

Deploy AI-native revenue cycle technology. Prioritize platforms with genuine machine learning (not rules-based automation marketed as AI), continuous learning from your data, payer-specific behavioral modeling, and cross-functional intelligence where insights in one domain improve performance in all others. Expect measurable results within 60-90 days.

Establish data governance. The data your AI system processes — claims, denials, payments, documentation — is a strategic asset. Ensure you retain ownership and portability rights. Establish data quality standards that maximize the training value of every transaction.

2027: Optimization and Expansion

Expand AI across the full revenue cycle. If your initial deployment focused on denial prevention and claims scrubbing, extend to AI-powered coding, automated prior authorization, intelligent payment posting, and underpayment detection. The compound value of AI — where each function informs every other function — only materializes when the full revenue cycle operates on the same AI platform.

Build a payer intelligence function. Move beyond tracking denial rates to modeling payer behavior proactively. Identify payers whose denial patterns are tightening. Detect authorization requirement changes before they result in denials. Use payer behavioral data to inform contract negotiations.

Monitor the regulatory landscape. Track CMS rulemaking, state legislation, and industry advocacy efforts. Ensure your AI systems' audit trails and explainability meet emerging compliance requirements before they become mandates.

2028 and beyond: Strategic positioning

Prepare for AI-to-AI claims interaction. As electronic interoperability standards mature and payers begin supporting real-time pre-adjudication queries, ensure your technology architecture can participate. This means API-ready platforms, structured clinical data capabilities, and AI systems that can represent clinical cases algorithmically in payer-defined formats.

Leverage your data advantage. By 2028, organizations that deployed AI in 2026 will have two-plus years of organization-specific model training. This data advantage translates to higher denial prediction accuracy, faster adaptation to payer behavior changes, and better outcomes in any claims resolution format — manual, automated, or AI-negotiated.

Participate in industry standards development. As the claims adjudication landscape evolves, the standards that govern AI-to-AI interaction will be defined. Organizations that participate in standards development — through HFMA, WEDI, HL7, and other bodies — shape the rules in ways that favor transparency, fairness, and provider interests.

The Ultimate Endgame: From Claims Adjudication to Automated Settlement

Look far enough ahead and the concept of claims adjudication itself may become an artifact.

The current system works like this: a provider delivers a service, generates documentation, assigns codes, submits a claim, and waits for the payer to decide whether to pay. The claim is a request. The adjudication is a judgment. The denial is a rejection. The appeal is a plea. The entire vocabulary reflects a power dynamic where the payer decides and the provider petitions.

AI changes this dynamic structurally. When both sides have comprehensive, real-time AI — when the provider's AI can document, code, and validate a claim simultaneously with the payer's AI verifying medical necessity, confirming eligibility, and calculating reimbursement — the sequential process collapses into a single transaction.

The service is delivered. The documentation is generated and analyzed. The clinical appropriateness is confirmed. The payment is calculated and initiated. All within minutes of the encounter, not weeks or months later.

This is automated settlement — and it's the logical endpoint of full AI deployment on both sides. Not because it's technologically utopian, but because it's economically rational. The administrative cost of the current claim-deny-appeal cycle exceeds $250 billion annually. Automated settlement reduces that cost by an order of magnitude. Every stakeholder — providers, payers, patients, regulators — benefits from the elimination of a friction layer that serves no clinical purpose.

What automated settlement requires

Standardized clinical data formats. AI-to-AI settlement requires both sides to process clinical information in interoperable formats. FHIR (Fast Healthcare Interoperability Resources) provides the foundation, but richer clinical data exchange standards are needed.

Transparent adjudication logic. Settlement requires agreement on the rules — or at least transparency about the rules each side is applying. This is where regulation plays a constructive role: mandating that payer adjudication criteria are accessible in machine-readable formats.

Trust frameworks. When AI systems transact on behalf of organizations, those organizations need assurance that the AI is operating within authorized parameters. This requires audit trails, performance monitoring, and governance structures that don't yet exist at scale.

Regulatory evolution. Current regulations assume a sequential claim-and-adjudication process. Automated settlement requires regulatory frameworks that accommodate real-time, AI-mediated payment transactions while maintaining the oversight protections that the current process provides.

The timeline

Elements of automated settlement will emerge in Medicare and Medicaid by 2029-2030, driven by CMS interoperability mandates. Commercial markets will follow more slowly, as payer participation requires either regulatory mandate or competitive pressure. Full automated settlement across the healthcare system is a 2032-2035 horizon — ambitious but not unrealistic given the pace of AI adoption and regulatory change.

The Decision Point

The claims adjudication landscape is changing. Payer AI is entrenched. Provider AI is maturing. The asymmetry that has defined the last decade — and driven denial rates to record levels — is closing. What replaces it will be some combination of adversarial escalation, collaborative optimization, and regulatory intervention.

But across all scenarios, one constant holds: the provider organization with better AI, better data, and earlier deployment achieves better financial outcomes. Not marginally better. Structurally better. The kind of better that compounds annually as AI models learn from more data, adapt to more payer behaviors, and optimize more revenue cycle functions.

The question for every healthcare organization is not whether AI will reshape claims adjudication. It is whether your organization will be the one shaping the landscape — or the one reacting to it, three years behind, with a data deficit that may never close.

The window to build the data advantage is now. The cost of waiting is not theoretical. It is $2.1 million to $3.6 million per year in preventable revenue loss for a $50 million organization — plus the compounding opportunity cost of organizational intelligence that was never built.

The AI-mediated claims future is coming. The only decision is whether you arrive prepared or scrambling.

---

QuickIntell's AI-native platform is built for the claims adjudication landscape that's emerging — not the one that's disappearing. With predictive denial prevention, payer-specific behavioral modeling, AI-powered coding, and cross-functional intelligence across the full revenue cycle, QuickIntell gives providers the technological foundation to compete in an AI-mediated world. Whether the future is adversarial, collaborative, or regulated, the organizations with better AI and deeper data will win. See how QuickIntell prepares your revenue cycle for what's next.

---

Internal Link References

• The Payer-Provider AI Arms Race: How Insurers Use AI to Deny Claims
• The $400 Billion Leak: Revenue Cycle Inefficiency
• The Healthcare CFO's Guide to AI
• Why Your RCM Vendor's "AI" Probably Isn't: Spotting AI-Washing
• How to Calculate the ROI of AI in Revenue Cycle Management
• AI-Native vs. AI Add-On: What's the Difference?
• What Is AI in Revenue Cycle Management?
• Building the Modern RCM Tech Stack